CompletedNCT02566057
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 15 Years to 64 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT00619723
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Bipolarity
CompletedNCT00602381
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherFrom 25 Years to 45 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT00602394
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 38 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT01570959
This study exists to explore whether the medication Quetiapine could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT00601536
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 39 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT01570894
This study exists to explore whether the medication Quetiapine could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT00601575
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherFrom 25 Years to 45 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT01570907
This study exists to explore whether the medication Quetiapine could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Roxane Laboratories
- Condition
- Bipolarity
CompletedNCT00000439
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Condition
- Bipolarity
CompletedNCT01429272
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Condition
- Depression
CompletedNCT01133821
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Holly Swartz
- Condition
- Depression
CompletedNCT00621777
This study exists to understand how the medication Varenicline holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Varenicline can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia
CompletedNCT02046369
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- Bulgaria, Colombia, France, Hungary, Mexico, Philippines, Poland, United States, South Korea, Ukraine
- Sponsor
- Sumitomo Pharma America, Inc.
- Condition
- Bipolarity
CompletedNCT02239094
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression
CompletedNCT02150577
This study exists to see whether the medication Evidence can make care clearer and more responsive. Researchers are trying to understand whether the medication Evidence can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 100 Years
- Countries
- United States
- Sponsor
- University of Arkansas
- Condition
- Depression
CompletedNCT01390389
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
DepressionOtherFrom 55 Years to 89 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Depression
CompletedNCT00458094
This study exists to explore whether a guided support group could improve care and understanding. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Schizophrenia
CompletedNCT01010204
This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- K.N. Roy Chengappa
- Condition
- Bipolarity
CompletedNCT02308956
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 25 Years
- Countries
- Ethiopia
- Sponsor
- University of Cape Town
- Condition
- Schizophrenia
TerminatedNCT00665444
This study exists to see whether the medication Aripiprazole can make care clearer and more responsive. Researchers are trying to understand whether the medication Aripiprazole can give earlier or clearer feedback during care.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- Bipolarity
CompletedNCT00908154
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- Biogen
- Condition
- Bipolarity
CompletedNCT02118623
This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can make support easier to access outside standard clinic visits.
BipolarityOtherFrom 21 Years to 65 Years
- Countries
- Australia
- Sponsor
- University of Melbourne
- Condition
- Bipolarity
CompletedNCT00488566
This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Biogen
- Condition
- Bipolarity
CompletedNCT02404246
This study exists to see whether the medication Peer is workable and worth testing more broadly. Researchers are trying to understand whether the medication Peer can give earlier or clearer feedback during care.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Kaiser Permanente
- Condition
- Bipolarity